MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Delving into Foundation Medicine's Recent Approvals

Dr. Geoffrey Oxnard vice president, global medical lead for Foundation Medicine's liquid biopsy portfolio, stops by Let's Talk Medtech to discuss the company’s recent FDA approvals. Oxnard also gives some insight into the liquid biopsy space.

Foundation Medicine has been busy with a number of approvals in recent weeks. The company, which was acquired by Roche in 2018 for $2.4 billion, recently won several approvals to be used as companion diagnostics. 

Dr. Geoffrey Oxnard vice president, global medical lead for  Foundation Medicine's liquid biopsy portfolio, stops by Let's Talk Medtech to discuss the company’s recent FDA approvals. Oxnard also gives some insight into the liquid biopsy space and the importance of tissue biopsies.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish